Catalent Inc is a company in the U.S. stock market and it is a holding in 155 U.S.-traded ETFs. CTLT has around 15.0M shares in the U.S. ETF market. The largest ETF holder of CTLT is the SPDR S&P 500 ETF Trust (SPY), with approximately 1.75M shares. Investors may also find of interest that the ETF with the largest allocation to CTLT stock is Invesco Dynamic Biotechnology & Genome ETF (PBE), with a portfolio weight of 5.77%. On average, U.S. ETFs allocate 0.39% of CTLT to their portfolios.
Additionally, CTLT is a favorite stock for Vanilla and Multi-factor ETFs. It is also most likely to belong to Broad-based ETFs. The best-performing ETF in the past 12 months with CTLT as a holding is the ProShares UltraPro S&P500 (UPRO), with a return of 122.65%.